Trained immunity, tolerance, priming and differentiation: distinct immunological processes

Autor: Boris Novakovic, Andreas Schlitzer, Giuseppe Matarese, Zahi A. Fayad, Willem J. M. Mulder, Henk Stunnenberg, Andrew R. DiNardo, Niels P. Riksen, Joachim L. Schultze, Christine Stabell Benn, Joseph C. Sun, Eva Kaufmann, Shabaana A. Khader, Michael H. Sieweke, Siroon Bekkering, Stephanie Fanucchi, Luis B. Barreiro, Maziar Divangahi, Mihai G. Netea, Reinout van Crevel, Jordi Ochando, Peter Aaby, Shruti Naik, Leo A. B. Joosten, Triantafyllos Chavakis, Musa M. Mhlanga, Eicke Latz, David L. Williams, Jos W. M. van der Meer, Luke A. J. O'Neill, Ramnik J. Xavier, Nigel Curtis, Robert W. Sauerwein, Kate L. Jeffrey, Edward R. Sherwood, Elaine Fuchs, Sebastian Weis, Nargis Khan, Melanie Hamon, Raphael Duivenwoorden, Keiko Ozato, Simone J.C.F.M. Moorlag, Jorge Domínguez-Andrés, Frank L. van de Veerdonk

Publikováno v: Nature Immunology, 22(1), 2-6. Nature Publishing Group
Nat Immunol
Nature Immunology
Nature Immunology, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature Immunology, 22, 2-6
Nature Immunology, 22, 1, pp. 2-6
Divangahi, M, Aaby, P, Khader, S A, Barreiro, L B, Bekkering, S, Chavakis, T, van Crevel, R, Curtis, N, DiNardo, A R, Dominguez-Andres, J, Duivenwoorden, R, Fanucchi, S, Fayad, Z, Fuchs, E, Hamon, M, Jeffrey, K L, Khan, N, Joosten, L A B, Kaufmann, E, Latz, E, Matarese, G, van der Meer, J W M, Mhlanga, M, Moorlag, S J C F M, Mulder, W J M, Naik, S, Novakovic, B, O’Neill, L, Ochando, J, Ozato, K, Riksen, N P, Sauerwein, R, Sherwood, E R, Schlitzer, A, Schultze, J L, Sieweke, M H, Benn, C S, Stunnenberg, H, Sun, J, van de Veerdonk, F L, Weis, S, Williams, D L, Xavier, R & Netea, M G 2021, ' Trained immunity, tolerance, priming and differentiation : distinct immunological processes ', Nature Immunology, vol. 22, no. 1, pp. 2–6 . https://doi.org/10.1038/s41590-020-00845-6
Nature Immunology, Nature Publishing Group, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature immunology 22(1), 2-6 (2021). doi:10.1038/s41590-020-00845-6
Nature immunology, 22(1), 2-6. Nature Publishing Group

The similarities and differences between trained immunity and other immune processes are the subject of intense interrogation. Therefore, a consensus on the definition of trained immunity in both in vitro and in vivo settings, as well as in experimen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f885f45a692b7911f7d93395e1feadca
http://www.scopus.com/inward/record.url?scp=85097285095&partnerID=8YFLogxK

Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens

Autor: Normand, Sylvain, Waldschmitt, Nadine, Neerincx, Andreas, Martinez-Torres, Ruben Julio, Chauvin, Camille, Couturier-Maillard, Aurelie, Boulard, Olivier, Cobret, Laetitia, Awad, Fawaz, Huot, Ludovic, Ribeiro-Ribeiro, Andre, Lautz, Katja, Ruez, Richard, Delacre, Myriam, Bondu, Clovis, Guilliams, Martin, Scott, Charlotte, Segal, Anthony, Amselem, Serge, Hot, David, Karabina, Sonia, Bohn, Erwin, Ryffel, Bernhard, Poulin, Lionel F, Kufer, Thomas A, Chamaillard, Mathias

Publikováno v: Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Nature Communications, 2018, 9, pp.5338. ⟨10.1038/s41467-018-07750-5⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), ⟨10.1038/s41467-018-07750-5⟩
Nature Communications, Nature Publishing Group, 2018, 9, pp.5338. ⟨10.1038/s41467-018-07750-5⟩
NATURE COMMUNICATIONS

Mutations in the nucleotide-binding oligomerization domain protein 12 (NLRP12) cause recurrent episodes of serosal inflammation. Here we show that NLRP12 efficiently sequesters HSP90 and promotes K48-linked ubiquitination and degradation of NOD2 in r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e50944fc482415c00f8748ca8a1bb1ad
http://link.springer.com/article/10.1038/s41467-018-07750-5

Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in septic patients

Autor: Uhel, Fabrice, Azzaoui, Imane, Grégoire, Murielle, Pangault, Céline, Dulong, Joelle, Tadié, Jean-Marc, Gacouin, Arnaud, Camus, Christophe, Cynober, Luc, Fest, Thierry, Le Tulzo, Yves, Roussel, Mikael, Tarte, Karin

Publikováno v: American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2017, 196 (3), pp.315-327. 〈10.1164/rccm.201606-1143OC〉
American Journal of Respiratory and Critical Care Medicine, 2017, 196 (3), pp.315-327. ⟨10.1164/rccm.201606-1143OC⟩
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2017, 196 (3), pp.315-327. ⟨10.1164/rccm.201606-1143OC⟩

International audience; Rationale - Sepsis induces a sustained immune dysfunction responsible for poor outcome and nosocomial infections. Myeloid-derived suppressor cells (MDSCs) described in cancer and inflammatory processes may be involved in sepsi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::55d973323239964fe647b9efca6bf217
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01480854/document

Liver macrophages: Friend or foe during hepatitis B infection?

Autor: Julie Lucifora, Suzanne Faure-Dupuy, David Durantel

Publikováno v: Liver International

International audience; The Hepatitis B virus chronically infects the liver of 250 million people worldwide. Over the past decades, major advances have been made in the understanding of Hepatitis B virus life cycle in hepatocytes. Beside these parenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598d094ee4c30ae2c6d4eb02caafda6a
https://pubmed.ncbi.nlm.nih.gov/29772112

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

Autor: Charlotte Charpentier, Véronique Joly, Carine Grondin, Sophie Tabuteau, Yazdan Yazdanpanah, François Raffi, André Cabié, Catherine Fagard, Patrick Yeni, Geneviève Chêne, Nathalie Colin de Verdiere, Diane Descamps

Publikováno v: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2013, 57 (2), pp.758-65. ⟨10.1128/AAC.01662-12⟩

We studied whether addition of enfuvirtide (ENF) to a background combination antiretroviral therapy (cART) would improve the CD4 cell count response at week 24 in naive patients with advanced HIV disease. ANRS 130 Apollo is a randomized study, conduc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4b1c68caf296a8d5bb398985a78d968
https://doi.org/10.1128/aac.01662-12